Meibomian Gland Dysfunction: Endocrine Aspects

Table 1

Descriptive statistics of serum hormone levels in both genders with respect to patients with seborrheic meibomian gland dysfunction and controls.

Hormones	Groups	N	Mean	SD
TSH (μIU/mL)	Patient	50	1,9188	1,11642
	Control	50	1,7696	1,00285
Bound-T3 (nmol/L)	Patient	50	1,5930	,32533
	Control	50	1,7884	1,42732
Bound-T4 (nmol/L)	Patient	50	81,0106	9,74157
	Control	50	83,3822	10,77266
Unbound-T3 (pmol/L)	Patient	50	4,9398	,75224
	Control	50	4,8162	,80606
Unbound-T4 (pmol/L)	Patient	50	14,4654	2,17048
	Control	50	14,4144	2,42574
FSH (mIU/mL)	Patient	50	3,5184	2,00730
	Control	50	4,2894	1,95526
LH (mIU/mL)	Patient	50	4,1122	3,37226
	Control	50	3,8674	2,64136
17-OH-Prog (ng/mL)	Patient	50	2,2484	3,90230
	Control	50	3,8628	6,99213
Estrodiol (pg/mL)	Patient	50	69,2944	56,87763
	Control	50	79,4172	63,27935
Prolactin (ng/mL)	Patient	50	17,9796	9,88949
	Control	50	18,3808	8,63397
Testosterone (ng/mL)	Patient	50	4,7764	3,66869
	Control	50	2,2714	2,71801
Cortisol (ng/mL)	Patient	50	147,0022	55,22128
	Control	50	130,5280	53,70375
DHEA-S μg/mL	Patient	50	370,7088	146,50287
	Control	50	238,5034	97,72012
Thyroglobulin (IU/mL)	Patient	50	11,9058	8,16335
	Control	50	11,0008	14,74698

DHEA-S: Dihydroepiandrosterone-sulphate, 17-OH-Prog: 17 Hydroxyprogesteron, FSH: Follicle stimulating hormone, LH: Lutenizing hormone, N: Number, TSH: thyroid stimulating hormone, T3: triiodothyronine, T4: thyroxine, SD: Standard deviation.